Table IVSurvival in patients with neuroendocrine tumors and liver metastases. The Lund series

TumorNo. of patientsMean survival (range; years)
Gastrinoma24 (1–7)
Glucagonoma46 (1–16)
Ppoma66 (1–11)
Somatostatinoma311 (4–15)
Non-functioning pancreatic endocrine tumor106 (1–12)

From: Neuroendocrine tumors metastatic to the liver

Cover of Surgical Treatment
Surgical Treatment: Evidence-Based and Problem-Oriented.
Holzheimer RG, Mannick JA, editors.
Munich: Zuckschwerdt; 2001.
Copyright © 2001, W. Zuckschwerdt Verlag GmbH.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.